|
Volumn 197, Issue 3, 2003, Pages 458-478
|
Stem cells in clinical practice
a b c d e |
Author keywords
DLI; Donor leukocyte infusion; Embryonic stem cells; ES; Graft versus host disease; GVHD; Hematopoietic stem cells; HSC
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IMMUNOSUPPRESSIVE AGENT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
BONE MARROW TRANSPLANTATION;
BREAST CANCER;
CARCINOMA;
CARDIOGENIC SHOCK;
CARDIOMYOPATHY;
CARDIOMYOPLASTY;
CELL DIFFERENTIATION;
CELL LINEAGE;
CLINICAL PRACTICE;
CONFERENCE PAPER;
DIABETES MELLITUS;
EMBRYO CELL;
FETUS CELL;
FOLLOW UP;
GRAFT VERSUS HOST REACTION;
HEART;
HEART INFARCTION;
HODGKIN DISEASE;
HUMAN;
MUSCULAR DYSTROPHY;
NERVE REGENERATION;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PARKINSON DISEASE;
PERINATAL PERIOD;
PRIORITY JOURNAL;
SKIN TRANSPLANTATION;
STEM CELL TRANSPLANTATION;
TISSUE REGENERATION;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ARTICLE;
BRAIN;
BRAIN DISEASE;
HEART DISEASE;
METHODOLOGY;
PHYSIOLOGY;
REGENERATION;
BRAIN;
BRAIN DISEASES;
HEART;
HEART DISEASES;
HUMANS;
NERVE REGENERATION;
REGENERATION;
STEM CELL TRANSPLANTATION;
|
EID: 0141610017
PISSN: 10727515
EISSN: None
Source Type: Journal
DOI: 10.1016/S1072-7515(03)00655-0 Document Type: Conference Paper |
Times cited : (12)
|
References (0)
|